Details for New Drug Application (NDA): 020544
✉ Email this page to a colleague
NDA 020544 describes JADELLE, which is a drug marketed by Population Council and is included in one NDA. Additional details are available on the JADELLE profile page.
The generic ingredient in JADELLE is levonorgestrel. There are twenty drug master file entries for this compound. Thirty-three suppliers are listed for this compound. Additional details are available on the levonorgestrel profile page.
The generic ingredient in JADELLE is levonorgestrel. There are twenty drug master file entries for this compound. Thirty-three suppliers are listed for this compound. Additional details are available on the levonorgestrel profile page.
Summary for 020544
| Tradename: | JADELLE |
| Applicant: | Population Council |
| Ingredient: | levonorgestrel |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 020544
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | IMPLANT;IMPLANTATION | Strength | 75MG/IMPLANT **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
| Approval Date: | Nov 1, 1996 | TE: | RLD: | Yes | |||||
Complete Access Available with Subscription
